NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ASPIVIX SA

ASPIVIX SA

Private
EpalingesHealthcare & Life Scienceshttps://www.aspivix.com/

Last Round

Crowdfunding

Jun 26, 2026

Est. Valuation

$24.05M

Total Funding Raised

$12.64M

Company Overview

ASPIVIX SA is a medical device company that develops innovative, suction-based cervical stabilizers designed to modernize gynecological procedures and improve patient comfort.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

medical devicegynecological instrumentscervical stabilizermedtechIUD insertionatraumatic instrumentstenaculum alternativehysteroscopyendometrial biopsysoft-suction technologysingle-use medical deviceswomen's health techfemtechsurgical instruments

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ASPIVIX SA Comps

Public and private peers based on sector, stage, and business model.

ASPIVIX SA comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ASPIVIX SA Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingJun 26, 2026
Series B ExtensionMar 14, 2025
Series A ExtensionNov 17, 2022
GrantNov 17, 2022
GrantJun 1, 2019
Series A
Aug 20, 2018

Key People

Founding team and executive leadership

Mathieu Horras

CEO, Co-founder, Board Director

Founding Team

ASPIVIX SA Investors

Notable investors and investment history

ASPIVIX SA investors
InvestorRounds
Eurostars SME programmeGrant
Business Angels SwitzerlandSeries A
4FOX VenturesSeries A Extension, Series A
InnosuisseGrant
Venture KickGrant
Capital CellCrowdfunding, Series B Extension
Zurcher KantonalbankSeries A, Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 15, 2025

    Grew 29% QoQ, from 17 to 22 employees.

ASPIVIX SA Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ASPIVIX SA Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ASPIVIX SA's valuation, stock price, and market status.

Firmographic Details

HeadquartersEpalinges
Employee Range23
Year Founded2018
Last FundingJun 26, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.